Package 0904-7416-61

{"route": ["ORAL"], "spl_id": "46d5c0d1-a97b-46d9-8cf4-994780673337", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["46d5c0d1-a97b-46d9-8cf4-994780673337"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-7416-61)  / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0904-7416-61", "marketing_start_date": "20251209"}], "brand_name": "Phenytoin Sodium", "product_id": "0904-7416_46d5c0d1-a97b-46d9-8cf4-994780673337", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0904-7416", "generic_name": "Phenytoin Sodium", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20251209", "listing_expiration_date": "20261231"}